Cracking the estrogen receptor's posttranslational code in breast tumors.

Abstract excerpt

Estrogen signaling pathways, because of their central role in regulating the growth and survival of breast tumor cells, have been identified as suitable and efficient targets for cancer therapies. Agents blocking estrogen activity are already widely used clinically, and many new molecules have entered clinical trials, but intrinsic or acquired resistance to treatment limits their efficacy. The basic molecular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylation
• Share to Antineoplastic Agents, Hormonal